URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sonal Munsiff

Concepts (197)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Tuberculosis
34
1996
54
9.050
Why?
Antitubercular Agents
21
1997
26
5.190
Why?
Mycobacterium tuberculosis
25
1996
51
4.730
Why?
Tuberculosis, Multidrug-Resistant
12
1997
12
3.390
Why?
Tuberculosis, Pulmonary
12
1997
29
2.900
Why?
New York City
35
1997
73
2.410
Why?
Tuberculin Test
9
2002
18
1.980
Why?
AIDS-Related Opportunistic Infections
10
1997
63
1.440
Why?
Rifampin
7
1997
14
1.360
Why?
Contact Tracing
6
2002
10
1.340
Why?
Drug Resistance, Multiple, Bacterial
3
2002
24
1.160
Why?
Disease Outbreaks
4
2003
117
1.120
Why?
Drug Resistance, Bacterial
6
2001
48
1.050
Why?
Disease Notification
3
2002
6
1.040
Why?
HIV Infections
7
1998
579
0.990
Why?
Emigration and Immigration
5
2003
24
0.920
Why?
Antibiotics, Antitubercular
4
1997
5
0.900
Why?
Humans
56
1993
36274
0.830
Why?
Adult
33
1997
11351
0.830
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2010
6
0.770
Why?
Isoniazid
6
2002
9
0.770
Why?
Intensive Care Units, Neonatal
1
2010
58
0.750
Why?
World Health Organization
3
2005
42
0.730
Why?
Male
37
1993
19675
0.720
Why?
Female
38
1993
19838
0.710
Why?
Adolescent
18
1997
4766
0.700
Why?
Middle Aged
27
1993
9837
0.700
Why?
Nucleic Acid Amplification Techniques
1
2009
12
0.690
Why?
Molecular Diagnostic Techniques
1
2009
11
0.680
Why?
Risk Factors
14
1997
2345
0.680
Why?
Patient Compliance
3
2002
174
0.610
Why?
Aged
21
1993
7269
0.600
Why?
Outcome and Process Assessment (Health Care)
2
2006
85
0.580
Why?
Directly Observed Therapy
2
2005
4
0.570
Why?
Cross Infection
5
1993
88
0.570
Why?
Child
13
2002
4155
0.560
Why?
Child, Preschool
10
2002
2660
0.530
Why?
Self Administration
1
2005
19
0.520
Why?
Treatment Refusal
1
2005
43
0.510
Why?
Public Health Administration
4
2002
20
0.510
Why?
Quality Assurance, Health Care
1
2006
123
0.510
Why?
Drug Monitoring
1
2004
41
0.490
Why?
Sputum
8
2002
57
0.490
Why?
Program Evaluation
4
2002
206
0.480
Why?
Health Plan Implementation
1
2003
20
0.460
Why?
Retrospective Studies
11
2001
2267
0.420
Why?
Multivariate Analysis
5
1997
541
0.380
Why?
Latent Tuberculosis
2
2009
2
0.380
Why?
Homeless Persons
3
2003
11
0.370
Why?
Laboratories
1
2000
25
0.370
Why?
DNA Fingerprinting
2
1997
10
0.340
Why?
Aged, 80 and over
7
1997
2529
0.340
Why?
Young Adult
7
2008
1059
0.320
Why?
DNA, Bacterial
4
1997
173
0.320
Why?
Oligonucleotide Array Sequence Analysis
1
2000
286
0.320
Why?
HIV Protease Inhibitors
1
1999
57
0.320
Why?
Treatment Outcome
7
2001
2615
0.320
Why?
False Positive Reactions
4
1997
88
0.310
Why?
HIV Seropositivity
2
2003
34
0.300
Why?
Urban Population
2
2007
169
0.290
Why?
Case Management
2
2006
23
0.290
Why?
Molecular Epidemiology
3
2002
11
0.260
Why?
Cluster Analysis
5
2002
88
0.260
Why?
Incidence
6
2001
685
0.250
Why?
Substance Abuse, Intravenous
3
1998
15
0.250
Why?
Genotype
6
2001
490
0.240
Why?
Health Personnel
2
2003
59
0.240
Why?
Polymorphism, Restriction Fragment Length
4
1997
37
0.230
Why?
Occupational Exposure
3
2003
114
0.220
Why?
Case-Control Studies
2
2005
617
0.220
Why?
Cohort Studies
4
2001
969
0.220
Why?
Time Factors
4
1998
3182
0.210
Why?
Substance-Related Disorders
2
2010
206
0.210
Why?
Sensitivity and Specificity
2
2000
905
0.200
Why?
Health Services Misuse
1
2010
11
0.190
Why?
Infectious Disease Transmission, Vertical
1
2010
47
0.190
Why?
Drug Resistance, Microbial
4
1993
120
0.190
Why?
Oxazolidinones
1
2010
2
0.180
Why?
Demography
1
2010
101
0.180
Why?
Rifabutin
2
2005
5
0.180
Why?
Acetamides
1
2010
32
0.180
Why?
Medication Adherence
1
2009
21
0.170
Why?
Pregnancy
3
2003
1966
0.170
Why?
Practice Guidelines as Topic
2
2007
302
0.160
Why?
Infant, Newborn
2
2006
1844
0.160
Why?
Prevalence
3
2003
562
0.150
Why?
Hospitalization
1
2010
399
0.150
Why?
Communication
1
2010
273
0.150
Why?
Communicable Disease Control
1
2007
27
0.150
Why?
Drug Administration Schedule
2
2005
366
0.150
Why?
AIDS Serodiagnosis
1
2007
9
0.150
Why?
Infant
4
2002
2278
0.150
Why?
Predictive Value of Tests
1
2009
606
0.150
Why?
Organizational Objectives
1
2006
27
0.140
Why?
Counseling
1
2007
66
0.140
Why?
Social Responsibility
1
2006
16
0.140
Why?
Public Sector
1
2006
4
0.140
Why?
BCG Vaccine
2
2003
23
0.140
Why?
Private Sector
1
2006
5
0.140
Why?
Ethambutol
1
2006
1
0.140
Why?
Reproducibility of Results
1
2010
877
0.140
Why?
DNA Transposable Elements
2
2001
42
0.140
Why?
Aza Compounds
1
2006
23
0.140
Why?
Skin
1
2008
377
0.140
Why?
Urban Health
1
2006
59
0.130
Why?
United States
3
2006
2688
0.130
Why?
Program Development
1
2006
81
0.130
Why?
Quinolines
1
2006
44
0.130
Why?
Health Knowledge, Attitudes, Practice
2
2005
267
0.130
Why?
Socioeconomic Factors
2
2003
404
0.130
Why?
Acquired Immunodeficiency Syndrome
2
1996
193
0.130
Why?
Pregnancy Complications, Infectious
1
2006
84
0.130
Why?
World Health
1
2005
63
0.120
Why?
Risk Assessment
2
2005
884
0.120
Why?
Microbial Sensitivity Tests
4
1993
170
0.120
Why?
Workplace
1
2003
21
0.120
Why?
CD4 Lymphocyte Count
3
1996
148
0.120
Why?
Schools
1
2003
42
0.120
Why?
Hospitals, Urban
1
2003
9
0.120
Why?
Community-Acquired Infections
1
2003
27
0.110
Why?
Residence Characteristics
1
2003
68
0.110
Why?
Regression Analysis
2
1998
527
0.110
Why?
Genetic Variation
1
2003
151
0.110
Why?
Database Management Systems
1
2002
13
0.110
Why?
Immunization Programs
1
2003
54
0.110
Why?
Referral and Consultation
3
2006
196
0.110
Why?
Serologic Tests
1
2002
24
0.100
Why?
Streptomycin
1
2001
8
0.100
Why?
Age Factors
1
2005
1128
0.100
Why?
Drug Users
2
2011
4
0.100
Why?
Drug Resistance, Multiple
2
1997
30
0.100
Why?
Equipment Contamination
1
2000
15
0.090
Why?
Prospective Studies
3
1997
1689
0.090
Why?
Mass Screening
1
2003
247
0.090
Why?
Specimen Handling
1
2000
71
0.090
Why?
Emigrants and Immigrants
2
2008
9
0.090
Why?
Drug Interactions
1
1999
183
0.080
Why?
HIV Seronegativity
1
1998
21
0.080
Why?
Confidence Intervals
1
1998
165
0.080
Why?
Ambulatory Care Facilities
2
2005
33
0.070
Why?
Data Interpretation, Statistical
1
1998
157
0.070
Why?
Proportional Hazards Models
1
1998
450
0.070
Why?
Odds Ratio
1
1998
315
0.070
Why?
Survival Rate
1
1998
618
0.070
Why?
Diagnostic Errors
1
1997
90
0.070
Why?
Disease Progression
1
1998
521
0.070
Why?
Anti-HIV Agents
2
2003
172
0.070
Why?
Virus Replication
1
1996
291
0.060
Why?
Bacterial Typing Techniques
2
2001
24
0.060
Why?
Tuberculin
2
1996
4
0.060
Why?
Cost-Benefit Analysis
2
2003
215
0.060
Why?
Enterococcus
1
1993
7
0.060
Why?
Gram-Positive Bacterial Infections
1
1993
17
0.060
Why?
Vancomycin
1
1993
29
0.060
Why?
Comorbidity
2
2003
380
0.050
Why?
Community-Institutional Relations
1
2011
29
0.050
Why?
Recurrence
2
2001
691
0.050
Why?
HIV-1
1
1996
536
0.050
Why?
Gastrointestinal Diseases
1
2010
37
0.040
Why?
Bone Marrow Diseases
1
2010
43
0.040
Why?
Sex Factors
1
2011
597
0.040
Why?
African Americans
1
2010
219
0.040
Why?
Nervous System Diseases
1
2010
147
0.040
Why?
Databases, Factual
1
2008
156
0.040
Why?
Capreomycin
1
2007
1
0.040
Why?
Drug Administration Routes
1
2007
10
0.040
Why?
Radiography, Thoracic
1
2007
62
0.040
Why?
Africa
1
2006
9
0.040
Why?
Feasibility Studies
1
2007
202
0.040
Why?
Follow-Up Studies
1
2011
1855
0.030
Why?
Patient Education as Topic
1
2007
214
0.030
Why?
Prenatal Care
1
2006
67
0.030
Why?
Population Surveillance
1
2006
136
0.030
Why?
Drug Therapy, Combination
1
2006
382
0.030
Why?
Treatment Failure
1
2005
128
0.030
Why?
Occupational Diseases
1
2005
88
0.030
Why?
Masks
1
2003
7
0.030
Why?
Methadone
1
2003
17
0.030
Why?
Infection Control
1
2003
23
0.030
Why?
Pyrazinamide
1
2003
2
0.030
Why?
Developing Countries
1
2003
41
0.030
Why?
HIV
1
2003
71
0.030
Why?
Clinical Trials as Topic
1
2007
671
0.030
Why?
Physician's Practice Patterns
1
2006
243
0.030
Why?
Interviews as Topic
1
2003
177
0.030
Why?
Health Care Costs
1
2003
113
0.030
Why?
New York
1
2005
1305
0.020
Why?
Breast Feeding
1
2003
183
0.020
Why?
Bacteriological Techniques
1
1997
32
0.020
Why?
Cell Death
1
1996
172
0.020
Why?
Survivors
1
1997
118
0.020
Why?
Lymphocytes
1
1996
291
0.020
Why?
CD8-Positive T-Lymphocytes
1
1996
224
0.010
Why?
Enterococcus faecalis
1
1993
22
0.010
Why?
DNA Probes
1
1993
88
0.010
Why?
Base Sequence
1
1993
1683
0.010
Why?
Molecular Sequence Data
1
1993
1988
0.010
Why?

Visualizations


Munsiff's Networks

Concepts
_
Similar People
_
Same Department